Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Registration Rights Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Registration Rights Agreement

Entities:

SkyePharma plc; Vital Living Inc; Vital Living, Inc.

Date:

2003

Size:

Preview shows 5KB of 38KB total

Price:

$42

ID:

#1256342

 

 

► Corporate ► Rights ► Registration Rights Agreements
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview


                               VITAL LIVING, INC.


REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of
December 15, 2003, is made by and between Vital Living, Inc., a Nevada
corporation (the "Company"), and the individuals and entities set forth on the
signature page hereto as such page may be amended from time to time to include
Additional Investors (as defined in Section 12) (each an "Investor" and
collectively, the "Investors").

WHEREAS, in connection with that certain Securities Purchase Agreement
by and among the Company and the Investors of even date herewith (the
"Securities Purchase Agreement"), the Company desires to sell to the Investors,
and the Investors desire to purchase from the Company, (a) certain senior
secured convertible notes (each a "Note" and collectively the "Notes"), and (b)
warrants (the "Warrants") to purchase shares of the Company's common stock,
$0.001 par value per share (the "Common Stock"); and

WHEREAS, to induce the Investors to purchase the Notes and the
Warrants, the Company has agreed to register the shares of Common Stock into
which the Notes may be convertible and the shares of Common Stock issuable upon
exercise of the Warrants pursuant to the terms of this Agreement;

NOW, THEREFORE, the Company and the Investors hereby covenant and agree
as follows:

1. Certain Definitions. As used in this Agreement, the following terms
shall have the following respective meanings:

"Commission" shall mean the Securities and Exchange Commission, or any
other federal agency at the time administering the Securities Act.

"Common Stock" shall mean the common stock, par value $0.001 per share,
of the Company.

"Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Commission thereunder, all as the
same shall be in effect at the time.

"Register," "registered" and "registration" each shall refer to a
registration effected by preparing and filing a Registration Statement or
statements or similar documents in compliance with the Securities Act and the
declaration or ordering of effectiveness of such Registration Statement or
document by the Commission.

"Registrable Securities" shall mean (i) the Common Stock issuable upon
conversion of the Notes (or that may be issuable upon the conversion of any
other equity security issuable upon conversion of the Notes), (ii) the Common
stock issuable upon exercise of the Warrants, and (iii) any other shares of
Common Stock issued as a dividend, interest payment or other distribution

<PAGE>

with respect to or in exchange for or in replacement of such Notes, Warrants or
Common Stock, provided, however, that shares of Common Stock which are
Registrable Securities shall cease to be Registrable Securities (x) upon any
sale pursuant to a Registration Statement or Rule 144 under the Securities Act,
(y) at such time, as they may be freely sold by the Investor pursuant to Rule
144(k) under the Securities Act or (z) upon any sale in any manner to a person
or entity which is not entitled, pursuant to Section 9, to the rights under this
Agreement.

"Securities Act" shall mean the Securities Act of 1933, as amended, and
the rules and regulations of the Commission thereunder, all as the same shall be
in effect at the applicable time.

"Capitalized terms" used but not defined herein shall have the meanings
set forth in the Securities Purchase Agreement or the Notes.

2. Registration.

(a) The Company shall file with the Commission a Registration Statement
on Form SB-2, S-1 or S-3 or such other appropriate form as may be prescribed by
the Securities Act, covering the Registrable Securities on or before January 14,
2004 (the "Target Registration Date"). In the event that (i) such Registration
Statement is not filed by the Target Registration Date or (ii) the Company fails
to respond in writing to comments received from the Commission within 30 days of
receipt of such comments, the Company will pay to each Investor, as liquidated
damages, an amount equal to 2.0% of the principal amount of such Investor's Note
for each 30-day period (or pro rata for any portion thereof) for so long as such
circumstance continues. The amounts payable as liquidated damages pursuant to
this paragraph shall be payable in lawful money of the United States and shall
be paid monthly within ten (10) business days of the last day of each month

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC